Breaking News Instant updates and real-time market news.

LIMAF

Linamar

$47.13 /

+0.894 (+1.93%)

12:52
08/11/22
08/11
12:52
08/11/22
12:52

Linamar price target raised to $86 from $80 at TD Securities

TD Securities analyst Brian Morrison raised the firm's price target on Linamar to $86 from $80 and keeps a Buy rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Earnings
Skillsoft cuts FY23 revenue view to $520M-$550M, consensus $566.9M » 16:26
12/06/22
12/06
16:26
12/06/22
16:26
SKIL

Skillsoft

$1.93 /

-0.06 (-3.02%)

Prior view was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

10/12/22 Citi
Skillsoft price target lowered to $4.50 from $13.50 at Citi
09/08/22 DA Davidson
Skillsoft price target lowered to $3 from $7 at DA Davidson
09/06/22 B. Riley
Skillsoft price target lowered to $6 from $11 at B. Riley
07/26/22 Oppenheimer
Skillsoft assumed with a Perform at Oppenheimer
SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

Hot Stocks
Midland States announces new $25M stock repurchase pact » 16:25
12/06/22
12/06
16:25
12/06/22
16:25
MSBI

Midland States

$26.74 /

+0.29 (+1.10%)

Midland States Bancorp…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSBI Midland States
$26.74 /

+0.29 (+1.10%)

MSBI Midland States
$26.74 /

+0.29 (+1.10%)

09/01/22 Raymond James
Midland States initiated with a Market Perform at Raymond James
MSBI Midland States
$26.74 /

+0.29 (+1.10%)

Conference/Events
Cross Country Healthcare management to meet with Jefferies » 16:25
12/06/22
12/06
16:25
12/06/22
16:25
CCRN

Cross Country Healthcare

$33.49 /

-1.36 (-3.90%)

Analyst Tanquilut to hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

Downgrade
PagSeguro Digital downgraded at Morgan Stanley on elevated interest rates » 16:23
12/06/22
12/06
16:23
12/06/22
16:23
PAGS

PagSeguro Digital

$9.10 /

-0.13 (-1.41%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

16:18 Today Morgan Stanley
PagSeguro Digital downgraded to Equal Weight from Overweight at Morgan Stanley
12/01/22 Goldman Sachs
PagSeguro Digital downgraded to Sell from Neutral at Goldman Sachs
11/29/22 JPMorgan
PagSeguro Digital downgraded to Neutral from Overweight at JPMorgan
11/23/22 Evercore ISI
PagSeguro Digital price target lowered to $13 from $16 at Evercore ISI
PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

Hot Stocks
Rani study for osteoporosis treatment RaniPill GO achieves all endpoints » 16:23
12/06/22
12/06
16:23
12/06/22
16:23
RANI

Rani Therapeutics

$7.45 /

-0.55 (-6.88%)

Rani Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RANI Rani Therapeutics
$7.45 /

-0.55 (-6.88%)

RANI Rani Therapeutics
$7.45 /

-0.55 (-6.88%)

10/11/22 UBS
Rani Therapeutics initiated with a Buy at UBS
07/27/22 H.C. Wainwright
Rani Therapeutics initiated with a Buy at H.C. Wainwright
06/13/22 Wedbush
Wedbush bullish on Rani Therapeutics, initiates with an Outperform
06/13/22 Wedbush
Rani Therapeutics initiated with an Outperform at Wedbush
RANI Rani Therapeutics
$7.45 /

-0.55 (-6.88%)

  • 12
    Aug
RANI Rani Therapeutics
$7.45 /

-0.55 (-6.88%)

RANI Rani Therapeutics
$7.45 /

-0.55 (-6.88%)

Downgrade
StoneCo downgraded to Equal Weight at Morgan Stanley on elevated interest rates » 16:22
12/06/22
12/06
16:22
12/06/22
16:22
STNE

StoneCo

$10.97 /

-0.305 (-2.71%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

16:18 Today Morgan Stanley
StoneCo downgraded to Equal Weight from Overweight at Morgan Stanley
12/01/22 Goldman Sachs
StoneCo upgraded to Neutral from Sell at Goldman Sachs
11/28/22 Evercore ISI
Evercore upgrades StoneCo to Outperform on revenue growth, less margin pressure
11/28/22 Evercore ISI
StoneCo upgraded to Outperform from In Line at Evercore ISI
STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

Hot Stocks
Dave & Buster's provides Q4 business update » 16:21
12/06/22
12/06
16:21
12/06/22
16:21
PLAY

Dave & Buster's

$36.14 /

-1.115 (-2.99%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

11/08/22 Deutsche Bank
Dave & Buster's upgraded to Buy from Hold at Deutsche Bank
10/05/22 Piper Sandler
Dave & Buster's price target lowered to $34 from $44 at Piper Sandler
09/09/22 Deutsche Bank
Dave & Buster's price target raised to $48 from $37 at Deutsche Bank
09/08/22 Truist
Dave & Buster's price target raised to $62 from $57 at Truist
PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

Hot Stocks
Rand Capital raises regular quarterly cash dividend 33% to 20c per share » 16:21
12/06/22
12/06
16:21
12/06/22
16:21
RAND

Rand Capital

$14.58 /

-0.11 (-0.75%)

Rand Capital announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Dave & Buster's reports Q3 EPS 4c, consensus 4c » 16:20
12/06/22
12/06
16:20
12/06/22
16:20
PLAY

Dave & Buster's

$36.14 /

-1.115 (-2.99%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

11/08/22 Deutsche Bank
Dave & Buster's upgraded to Buy from Hold at Deutsche Bank
10/05/22 Piper Sandler
Dave & Buster's price target lowered to $34 from $44 at Piper Sandler
09/09/22 Deutsche Bank
Dave & Buster's price target raised to $48 from $37 at Deutsche Bank
09/08/22 Truist
Dave & Buster's price target raised to $62 from $57 at Truist
PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

Syndicate
Uniti Group announces $300M convertible senior notes offering » 16:20
12/06/22
12/06
16:20
12/06/22
16:20
UNIT

Uniti Group

$7.06 /

-0.195 (-2.69%)

Uniti Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNIT Uniti Group
$7.06 /

-0.195 (-2.69%)

UNIT Uniti Group
$7.06 /

-0.195 (-2.69%)

11/13/22 Citi
Uniti Group price target lowered to $9 from $12 at Citi
UNIT Uniti Group
$7.06 /

-0.195 (-2.69%)

UNIT Uniti Group
$7.06 /

-0.195 (-2.69%)

Earnings
Zuora narrows FY23 FY23 EPS view to (16c)-(15c) from (18c)-(14c) » 16:20
12/06/22
12/06
16:20
12/06/22
16:20
ZUO

Zuora

$7.20 /

-0.18 (-2.44%)

Consensus (16c). Cuts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

11/28/22 Needham
Needham adds HubSpot to Conviction List, removes Zuora
10/21/22 Goldman Sachs
Zuora initiated with a Neutral at Goldman Sachs
08/25/22 Needham
Zuora price target lowered to $15 from $24 at Needham
08/25/22 Craig-Hallum
Zuora price target lowered to $16 from $22 at Craig-Hallum
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

Options
Closing CBOE SPX and VIX Index summary for December 6th » 16:20
12/06/22
12/06
16:20
12/06/22
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Recommendations
Achilles Therapeutics price target lowered to $8 from $10 at Piper Sandler » 16:19
12/06/22
12/06
16:19
12/06/22
16:19
ACHL

Achilles Therapeutics

$1.50 /

-0.215 (-12.57%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

15:11 Today Chardan
Achilles Therapeutics price target lowered to $17 from $20 at Chardan
05/27/22 Piper Sandler
Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
05/10/22 Piper Sandler
Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
03/01/22 Piper Sandler
Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

Earnings
Zuora sees Q4 adjusted EPS (7c)-(6c), consensus (3c) » 16:19
12/06/22
12/06
16:19
12/06/22
16:19
ZUO

Zuora

$7.20 /

-0.18 (-2.44%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

11/28/22 Needham
Needham adds HubSpot to Conviction List, removes Zuora
10/21/22 Goldman Sachs
Zuora initiated with a Neutral at Goldman Sachs
08/25/22 Needham
Zuora price target lowered to $15 from $24 at Needham
08/25/22 Craig-Hallum
Zuora price target lowered to $16 from $22 at Craig-Hallum
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

Hot Stocks
Smith & Wesson Brands falls 8% to $10.80 after Q2 results miss estimates  16:18
12/06/22
12/06
16:18
12/06/22
16:18
SWBI

Smith & Wesson Brands

$11.80 /

-0.275 (-2.28%)

 
ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

09/09/22 Lake Street
Smith & Wesson Brands price target lowered to $22 from $26 at Lake Street
SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

Downgrade
PagSeguro Digital downgraded to Equal Weight from Overweight at Morgan Stanley » 16:18
12/06/22
12/06
16:18
12/06/22
16:18
PAGS

PagSeguro Digital

$9.10 /

-0.13 (-1.41%)

Morgan Stanley downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

12/01/22 Goldman Sachs
PagSeguro Digital downgraded to Sell from Neutral at Goldman Sachs
11/29/22 JPMorgan
PagSeguro Digital downgraded to Neutral from Overweight at JPMorgan
11/23/22 Evercore ISI
PagSeguro Digital price target lowered to $13 from $16 at Evercore ISI
11/23/22 Susquehanna
PagSeguro Digital results largely inline with expectations, says Susquehanna
PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

PAGS PagSeguro Digital
$9.10 /

-0.13 (-1.41%)

Downgrade
StoneCo downgraded to Equal Weight from Overweight at Morgan Stanley » 16:18
12/06/22
12/06
16:18
12/06/22
16:18
STNE

StoneCo

$10.97 /

-0.305 (-2.71%)

Morgan Stanley downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

12/01/22 Goldman Sachs
StoneCo upgraded to Neutral from Sell at Goldman Sachs
11/28/22 Evercore ISI
Evercore upgrades StoneCo to Outperform on revenue growth, less margin pressure
11/28/22 Evercore ISI
StoneCo upgraded to Outperform from In Line at Evercore ISI
09/06/22 Goldman Sachs
StoneCo downgraded to Sell from Neutral at Goldman Sachs
STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

STNE StoneCo
$10.97 /

-0.305 (-2.71%)

Earnings
Zuora reports Q3 adjusted EPS (2c), consensus (6c) » 16:18
12/06/22
12/06
16:18
12/06/22
16:18
ZUO

Zuora

$7.20 /

-0.18 (-2.44%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

11/28/22 Needham
Needham adds HubSpot to Conviction List, removes Zuora
10/21/22 Goldman Sachs
Zuora initiated with a Neutral at Goldman Sachs
08/25/22 Needham
Zuora price target lowered to $15 from $24 at Needham
08/25/22 Craig-Hallum
Zuora price target lowered to $16 from $22 at Craig-Hallum
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

Earnings
Avid Bioservices raises FY23 revenue view to $145M-$150M from $140M-$145M » 16:18
12/06/22
12/06
16:18
12/06/22
16:18
CDMO

Avid Bioservices

$14.84 /

-0.565 (-3.67%)

Consensus $143.81M. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

Conference/Events
Avrobio to hold a virtual event » 16:17
12/06/22
12/06
16:17
12/06/22
16:17
AVRO

Avrobio

/

+

Management host a virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVRO Avrobio
/

+

AVRO Avrobio
/

+

05/11/22 Wedbush
Avrobio price target lowered to $4 from $14 at Wedbush
05/11/22 Barclays
Avrobio price target lowered to $4 from $6 at Barclays
01/06/22 Mizuho
Avrobio price target lowered to $6 from $28 at Mizuho
01/05/22 Morgan Stanley
Avrobio price target lowered to $3 from $7 at Morgan Stanley
AVRO Avrobio
/

+

Earnings
ADMA Biologics sees Q revenue $48M-$50M, consensus $40.66M » 16:17
12/06/22
12/06
16:17
12/06/22
16:17
ADMA

ADMA Biologics

$3.17 /

-0.08 (-2.47%)

Sees FY22 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$3.17 /

-0.08 (-2.47%)

ADMA ADMA Biologics
$3.17 /

-0.08 (-2.47%)

10/12/22 Mizuho
ADMA Biologics initiated with a Buy at Mizuho
07/25/22 H.C. Wainwright
ADMA Biologics price target lowered to $4 from $6 at H.C. Wainwright
ADMA ADMA Biologics
$3.17 /

-0.08 (-2.47%)

Earnings
Guidewire raises FY23 revenue view to $886M-$896M from $885M-$895M  16:17
12/06/22
12/06
16:17
12/06/22
16:17
GWRE

Guidewire

$56.67 /

-1.08 (-1.87%)

Consensus $889.41M.

ShowHide Related Items >><<
GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

12/01/22 DA Davidson
Guidewire price target lowered to $90 from $96 at DA Davidson
12/01/22 JPMorgan
Guidewire initiated with an Overweight at JPMorgan
09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

Technical Analysis
NASDAQ market internals summary » 16:17
12/06/22
12/06
16:17
12/06/22
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Initiation
QuidelOrtho initiated with an Outperform at RBC Capital » 16:16
12/06/22
12/06
16:16
12/06/22
16:16
QDEL

QuidelOrtho

$92.21 /

-1.43 (-1.53%)

RBC Capital analyst Conor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QDEL QuidelOrtho
$92.21 /

-1.43 (-1.53%)

QDEL QuidelOrtho
$92.21 /

-1.43 (-1.53%)

10/14/22 UBS
QuidelOrtho upgraded to Neutral from Sell at UBS
09/19/22 Citi
QuidelOrtho initiated with a Neutral at Citi
08/31/22 Raymond James
D.R. Horton, QuidelOrtho added to Raymond James 'Analyst Current Favorites' list
07/20/22 UBS
QuidelOrtho initiated with a Sell at UBS
QDEL QuidelOrtho
$92.21 /

-1.43 (-1.53%)

QDEL QuidelOrtho
$92.21 /

-1.43 (-1.53%)

Earnings
Guidewire sees Q2 revenue $221M-$226M, consensus $221.37M » 16:16
12/06/22
12/06
16:16
12/06/22
16:16
GWRE

Guidewire

$56.67 /

-1.08 (-1.87%)

Sees Q2 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

12/01/22 DA Davidson
Guidewire price target lowered to $90 from $96 at DA Davidson
12/01/22 JPMorgan
Guidewire initiated with an Overweight at JPMorgan
09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.